Latest Novonesis News & Updates

See the latest news and media coverage for Novonesis. We track all announcements, press releases, and industry mentions in real time, all in one place.

Novonesis

Global biosolutions company

novonesis.com

Company type: Public company
Number of employees: 11,000+
Industry: Specialty Chemicals

Last updated October 14

Latest news about Novonesis

In short: Novonesis delivered strong growth, raised guidance, and advanced major investments in India, Thailand, and acquisitions.

Company announcements

September 2 Novonesis

Novonesis invests 600 million euros in Indian enzyme plant

The expansion boosts global biosolutions capacity to meet rising demand while enhancing water and energy efficiency for sustainable manufacturing by 2030.

August 19 Novonesis

Novonesis shares H1 2026 results and raises annual guidance

The company reports strong organic sales growth, approves a one billion euro share buyback program, and maintains an adjusted EBITDA margin target above thirty seven percent.

June 23 Novonesis

Novonesis outlines Household Care growth strategy

The presentation highlights innovation leadership, regional application excellence, and accelerating biosolutions market.

June 17 Novonesis

Novonesis partners with Nhà Xanh to boost Vietnam's biofuel production

The MoU aims to improve ethanol yields and support the country's E10 rollout, strengthening energy security.

Media coverage

October 14 Ad Hoc News

Novonesis stock stands 1.27 percent below its 52-week high

Organic growth guidance rose to 7-8 percent from 5-7 percent. Novonesis stock costs EUR 61.39 on October 15, 2026 against a 52-week high of EUR...

October 5 OpenPR

Industrial Enzymes Market Gains Momentum as Novonesis Invests €600 Million in Next-Generation India Facility

Novonesis announced a 600 million investment in September 2026 to expand its Patalganga site in India and build a next generation enzyme production facility with...

September 30 Securities.io

Novonesis Closes MicroBioGen Acquisition After Regulatory Approvals

Novonesis announced on October 1, 2026, that it has completed its acquisition of MicroBioGen, an Australian biotechnology company focused on yeast strains for industrial applications...

September 20 Ad Hoc News

Novonesis stock holds ground as investors weigh recent share volatility and latest earnings

Novonesis, DK0060336014 Novonesis stock holds ground as investors weigh recent share volatility and latest earnings Published on 09/20/2026 at 19:11 \| Editorial responsibility: Ra...

Never miss news about Novonesis

Track Novonesis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.